iShares Biotechnology ETF
956 hedge funds and large institutions have $6.37B invested in iShares Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 305 increasing their positions, 248 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more call options, than puts
Call options by funds: $453M | Put options by funds: $409M
3.63% less ownership
Funds ownership: 66.89% → 63.26% (-3.6%)
10% less capital invested
Capital invested by funds: $7.09B → $6.37B (-$721M)
Holders
956
Holding in Top 10
10
Calls
$453M
Puts
$409M
Top Buyers
| 1 | +$115M | |
| 2 | +$70.8M | |
| 3 | +$33.7M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$25.9M |
| 5 |
DC
DeDora Capital
Napa,
California
|
+$24.8M |
Top Sellers
| 1 | -$200M | |
| 2 | -$182M | |
| 3 | -$165M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$103M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$59.1M |